GlaxoSmithKline — Drug Prices & Medicare Spending

GlaxoSmithKline manufactures 16 drugs tracked by Medicare Part D with total spending of $9.3B.

Drugs Tracked

$9.3B

Medicare Spending

$125.77

Avg Cost/Claim

94%

Have Generics

GlaxoSmithKline Drugs — Ranked by Medicare Spending

#	Drug	Generic Name	Cost/Claim	Medicare Spending	YoY Change	Generic?
1	Trelegy Ellipta	Fluticasone/Umeclidinium/Vilanterol	$380.00	$2.9B	+19.8%	No
2	Nucala	Mepolizumab	$2,720.00	$1.5B	+12.4%	Yes
3	Breo Ellipta	Fluticasone/Vilanterol	$221.00	$1.2B	-4.3%	Yes
4	Benlysta	Belimumab	$4,710.00	$876.0M	+14.6%	Yes
5	Advair Diskus	Fluticasone/Salmeterol	$159.00	$678.0M	-18.9%	Yes
6	Anoro Ellipta	Umeclidinium/Vilanterol	$229.00	$567.0M	+4.2%	Yes
7	Incruse Ellipta	Umeclidinium	$185.00	$345.0M	-2.4%	Yes
8	Flolan	Epoprostenol	$19,167.00	$345.0M	-4.8%	Yes
9	Bupropion	Bupropion Hydrochloride	$12.00	$178.0M	-22.4%	Yes
10	Lamotrigine	Lamotrigine	$17.00	$145.0M	-22.4%	Yes
11	Carvedilol	Carvedilol	$11.00	$123.0M	-24.6%	Yes
12	Paroxetine	Paroxetine Hydrochloride	$18.00	$89.0M	-22.4%	Yes
13	Sumatriptan	Sumatriptan	$18.00	$89.0M	-22.4%	Yes
14	Ropinirole	Ropinirole Hydrochloride	$48.00	$89.0M	-22.6%	Yes
15	Valacyclovir	Valacyclovir	$18.00	$89.0M	-12.4%	Yes
16	Lovaza	Omega-3-Acid Ethyl Esters	$143.00	$89.0M	-34.2%	Yes

GlaxoSmithKline manufactures 16 drugs tracked by Medicare Part D, with total annual spending of $9.3B.

Flolan (Epoprostenol) is the most expensive at $19,167.00 per claim.

15 of 16 GlaxoSmithKline drugs (94%) have generic alternatives available. Generic drugs can save patients 30-80% compared to brand-name versions.